Showing results (921-930 of 1,984) with videos related to

Sort By:
Pageof 199
The Lancet. Neurology|June 13, 2016
Risk of intracerebral haemorrhage with alteplase after acute ischaemic stroke: a secondary analysis of an individual patient data meta-analysisWilliam N Whiteley, Jonathan Emberson, Kennedy R Lees, et al.
The Lancet. Neurology|June 16, 2016
Fresh frozen plasma versus prothrombin complex concentrate in patients with intracranial haemorrhage related to vitamin K antagonists (INCH): a randomised trialThorsten Steiner, Sven Poli, Martin Griebe, et al.
The Lancet. Neurology|June 16, 2016
Effect of baseline Alberta Stroke Program Early CT Score on safety and efficacy of intra-arterial treatment: a subgroup analysis of a randomised phase 3 trial (MR CLEAN)Albert J Yoo, Olvert A Berkhemer, Puck S S Fransen, et al.
The Lancet. Neurology|June 14, 2016
Global burden of stroke and risk factors in 188 countries, during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013Valery L Feigin, Gregory A Roth, Mohsen Naghavi, et al.
The Lancet. Neurology|February 17, 2016
Safety and efficacy of the selective sphingosine 1-phosphate receptor modulator ozanimod in relapsing multiple sclerosis (RADIANCE): a randomised, placebo-controlled, phase 2 trialJeffrey A Cohen, Douglas L Arnold, Giancarlo Comi, et al.
The Lancet. Neurology|February 17, 2016
Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trialHong Sun, David W Dodick, Stephen Silberstein, et al.
The Lancet. Neurology|August 1, 2015
Incidence, outcome, risk factors, and long-term prognosis of cryptogenic transient ischaemic attack and ischaemic stroke: a population-based studyLinxin Li, Gabriel S Yiin, Olivia C Geraghty, et al.
The Lancet. Neurology|September 7, 2014
Oral teriflunomide for patients with a first clinical episode suggestive of multiple sclerosis (TOPIC): a randomised, double-blind, placebo-controlled, phase 3 trialAaron E Miller, Jerry S Wolinsky, Ludwig Kappos, et al.
The Lancet. Neurology|July 11, 2014
Investigation of the KIR4.1 potassium channel as a putative antigen in patients with multiple sclerosis: a comparative studyAdipong Brickshawana, Shannon R Hinson, Michael F Romero, et al.
The Lancet. Neurology|December 2, 2014
Thrombolysis and clinical outcome in patients with stroke after implementation of the Tyrol Stroke Pathway: a retrospective observational studyJohann Willeit, Theresa Geley, Johannes Schöch, et al.
Pageof 199